← Eichor
Study identifier: NCT06888999 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

In Vitro Exposure by VR to Enhance Return to Work After Sick Leave Due to Mental Health Related Complaints

Condition: Return to Work · Occupational Stress · Self-Efficacy  ·  Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

PhaseNA
Planned participants118
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The goal of this pilot randomised controlled trial is to investigate whether in vitro exposure by VR enhances return to work (RTW) in flight cabin crew on sick leave with mental health related complaints. The main research questions are: 1. Does VR enhances time to RTW? 2. Does VR increase self-efficacy and positive cognitions regarding RTW, and decrease job anxiety? Researchers will compare a control group receiving care as usual as provided by the occupational physician and a psychologist to an intervention group receiving care as usual plus (al least) one session with VR-glasses in which participants are virtually exposed to their workplace.

This description comes directly from the study's public registry record.

Talk to the study team

Maartje C. Bakhuys Roozeboom, PhD  ·  0031619352778  ·  m.c.bakhuysroozeboom@amsterdamumc.nl

Always discuss trial participation with your own doctor first.

Locations (1)

KLM Health ServicesSchiphol, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06888999